SelectION
San Diego
About SelectION
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases and selecting cancer indications by targeting autoreactive, chronically activated T cells. It has established a technology platform to develop potent and highly selective peptide blockers for ion channels involved in various diseases. Its platform enables to optimize the target selectivity, providing the opportunity to develop drugs with significantly improved efficacy and safety profiles.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.6M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2025)
- Website: selectiontherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/selection-70204 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.